2-Methylglyoxal (MG) metabolic pathway is one of the pathways that show significant elevations in various tumor cells and their members, glyoxalase I (GLO1) and glyoxalase II (GLO2), are considered as important drug targets (Fig. 1)3. Here, GLO1 is linked to neoplasm.